分子診断ツールの進化とエビ食品産業の成長がエビ病診断薬市場を促進する

Advancement in Molecular Diagnosis Tools and Growing Shrimp Food Industry Will Propel Shrimp Disease Diagnostics Market

エビの病気診断薬市場：報告書の範囲 Persistence Market Research社の調査レポート「世界のエビ病診断市場」は、機会や現在の市場環境を評価し、詳細な分析、市場に影響を与える対応セクションに関する最新情... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Persistence Market Research パーシスタンスマーケットリサーチ	2023年3月27日	US$4,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	215	英語

目次
図表リスト

サマリー

エビの病気診断薬市場：報告書の範囲

Persistence Market Research社の調査レポート「世界のエビ病診断市場」は、機会や現在の市場環境を評価し、詳細な分析、市場に影響を与える対応セクションに関する最新情報を提供します。この調査レポートは、市場の促進要因、阻害要因、動向、機会を含む現在の市場力学に関する詳細な洞察を提供します。この市場調査の主な目的は、2023年〜2033年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。

市場の成功的な成長のための重要な指標は、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）を含むこの包括的なレポートで提示され、Persistence Market Research社の調査で網羅的に説明されています。この調査研究は、エビ病診断製品の需要と調査期間中の定量的な発展機会を知るために読者をサポートすることができます。

この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、エビ病診断市場で繁栄するために適切なビジネス戦略を開発するのに役立ちます。エビ病診断市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家は、このPersistence Market Researchの調査で示された洞察と情報を活用できます。

市場統計、およびエビ病診断市場のビジネスシナリオに影響を与えるマクロ経済およびミクロ経済の変数に関連する情報も、現在の研究に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートで遭遇することができます。さらに、本レポートで提出されたデータにより、業界のマイナーな企業や新規参入者は、市場で牽引力を発揮するために適切な企業選択をする際に役立つことができます。

主要な市場セグメント

Persistence Market Research社のエビ病診断市場に関する調査レポートは、試薬キット、疾患、エンドユーザー、地域の4つの重要なセグメントに分けて情報を提供しています。本レポートでは、これらのカテゴリに関連する重要な市場力学と成長パラメータに関する包括的なデータと情報を提供します。

試薬キット
迅速検査キット
アッセイベースキット
疾患別
WSSV (白点症候群ウイルス)
TSV（タウラ・シンドローム・ウイルス）
YHV/GAV（黄班・鰓関連ウイルス）
IHHNV（伝染性低身長・造血器ウイルス）（Infectious Hypodermal and Hematopoietic Virus
HPV（Hepatopancreatic Parvovirus：肝膵パルボウイルス）
MBV（Monodon Baculovirus：モノドンバキュロウイルス）
IMNV (感染性筋壊死ウイルス)
NHP-B（壊死性肝膵炎菌）
MoV（ムリヤン・ウイルス）
早期死亡症候群(EMS)
エンドユーザー
漁業
水産養殖研究所
海洋研究所
教育・研究機関
その他
地域
北アメリカ
中南米
欧州
南アジア
東アジア
オセアニア
中東・アフリカ(MEA)
報告書に記載されている主な質問

今後数年間、エビの病気診断で最も収益性の高い市場であり続けるのはどの地域か？
トレンドの変化は市場にどのような影響を与えるか？
COVID-19の危機は市場成長にどのような影響を与えたか？
市場関係者はどのようにして先進国の低空飛行の機会を獲得することができるのか？
市場関係者は、このランドスケープにおける自らのポジションを形成するために、どのような戦略を持っているのか？
投資家が市場に投資する際に認識する必要があり、取り組む可能性のある抑制要因とは？
市場に影響を与える開発動向は何か？
エビ病診断市場の企業は、先進国および新興国での成長機会をどのように利用できるのか？
調査方法

Persistence Market Research社の調査レポートでは、エビ病診断市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論を得るために、独自の調査手法を利用しています。この調査手法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。

市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行った。

一次および二次リソースから取得した包括的な情報は、市場に参入している企業からの検証として機能し、エビ病診断市場の成長見通しに関するPersistence Market Researchの予測をより正確で信頼できるものにします。

ページTOPに戻る

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Market Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis

4.2. Recent Product Approvals

4.3. Regulatory Landscape

4.4. Reimbursement Scenario

4.5. Supply Chain Analysis

4.6. Porter’s Analysis

4.7. PESTLE Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP outlook

5.1.2. Global Healthcare Expenditure Outlook

5.1.3. Global Animal Diagnostics Market Outlook

5.2. Forecast Factors - Relevance & Impact

5.2.1. Growing Healthcare Expenditure

5.2.2. Historic and Current Revenue of Key Players

5.2.3. Increasing Adoption of Diagnostic Tools

5.2.4. Rising Incidences of Infectious Diseases

5.2.5. Introduction of New and Advance Reagent Kits and Devices

5.2.6. High Cost of Diagnostic kits

5.2.7. Increasing Research and Development Activities to Develop Diagnostic Tools

5.2.8. Strategic Collaboration Among Players

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis

6.1.1. By Reagent Kits

6.1.2. By Disease

6.1.3. By End User

6.1.4. By Country

6.2. 2022 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014–2022 and Forecast, 2023–2033

7.1. Historical Market Value (US$ Mn) Analysis, 2014–2022

7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2014–2022 and Forecast 2023–2033, By Reagent Kits

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis by Reagent Kits, 2014–2022

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Reagent Kits, 2023–2033

8.3.1. Rapid Testing Kits

8.3.2. Assay Based Kits

8.4. Market Attractiveness Analysis by Reagent Kits

9. Global Market Analysis 2014–2022 and Forecast 2023–2033, By Disease

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2014–2022

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2023–2033

9.3.1. WSSV (White Spot Syndrome Virus)

9.3.2. TSV (Taura Syndrome Virus)

9.3.3. YHV/GAV (Yellow Head/Gill Associated Virus)

9.3.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)

9.3.5. HPV (Hepatopancreatic Parvovirus)

9.3.6. MBV (Monodon Baculovirus)

9.3.7. IMNV (Infectious Myonecrosis Virus)

9.3.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)

9.3.9. MoV (Mourilyan Virus)

9.3.10. Early Mortality Syndrome (EMS)

9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2014–2022 and Forecast 2023–2033, By End User

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis by End User, 2014–2022

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2023–2033

10.3.1. Fisheries

10.3.2. Aquaculture Laboratories

10.3.3. Marine Laboratories

10.3.4. Education and Research Institutes

10.3.5. Others

10.4. Market Attractiveness Analysis by End User

11. Global Market Analysis 2014–2022 and Forecast 2023–2033, By Region

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2014–2022

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2023–2033

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East & Africa

11.4. Market Attractiveness Analysis by Region

12. North America Market Analysis 2014–2022 and Forecast 2023–2033

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014–2022

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Reagent Kits

12.3.3. By Disease

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Reagent Kits

12.4.3. By Disease

12.4.4. By End User

12.5. Market Trends

12.6. Key Market Participants - Intensity Mapping

12.7. Drivers and Restraints - Impact Analysis

12.8. Country Level Analysis & Forecast

12.8.1. U.S. Market

12.8.1.1. Introduction

12.8.1.2. Market Analysis and Forecast by Market Taxonomy

12.8.1.2.1. By Reagent Kits

12.8.1.2.2. By Disease

12.8.1.2.3. By End User

12.8.2. Canada Market

12.8.2.1. Introduction

12.8.2.2. Market Analysis and Forecast by Market Taxonomy

12.8.2.2.1. By Reagent Kits

12.8.2.2.2. By Disease

12.8.2.2.3. By End User

13. Latin America Market Analysis 2014–2022 and Forecast 2023–2033

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014–2022

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

13.3.1. By Country

13.3.1.1. Mexico

13.3.1.2. Brazil

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Reagent Kits

13.3.3. By Disease

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Reagent Kits

13.4.3. By Disease

13.4.4. By End User

13.5. Market Trends

13.6. Key Market Participants - Intensity Mapping

13.7. Drivers and Restraints - Impact Analysis

13.8. Country Level Analysis & Forecast

13.8.1. Mexico Market Analysis

13.8.1.1. Introduction

13.8.1.2. Market Analysis and Forecast by Market Taxonomy

13.8.1.2.1. By Reagent Kits

13.8.1.2.2. By Disease

13.8.1.2.3. By End User

13.8.2. Brazil Market Analysis

13.8.2.1. Introduction

13.8.2.2. Market Analysis and Forecast by Market Taxonomy

13.8.2.2.1. By Reagent Kits

13.8.2.2.2. By Disease

13.8.2.2.3. By End User

13.8.3. Argentina Market Analysis

13.8.3.1. Introduction

13.8.3.2. Market Analysis and Forecast by Market Taxonomy

13.8.3.2.1. By Reagent Kits

13.8.3.2.2. By Disease

13.8.3.2.3. By End User

14. Europe Market Analysis 2014–2022 and Forecast 2023–2033

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014–2022

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Reagent Kits

14.3.3. By Disease

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Reagent Kits

14.4.3. By Disease

14.4.4. By End User

14.5. Market Trends

14.6. Key Market Participants - Intensity Mapping

14.7. Drivers and Restraints - Impact Analysis

14.8. Country Level Analysis & Forecast

14.8.1. Germany Market Analysis

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. By Reagent Kits

14.8.1.2.2. By Disease

14.8.1.2.3. By End User

14.8.2. Italy Market Analysis

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. By Reagent Kits

14.8.2.2.2. By Disease

14.8.2.2.3. By End User

14.8.3. France Market Analysis

14.8.3.1. Introduction

14.8.3.2. Market Analysis and Forecast by Market Taxonomy

14.8.3.2.1. By Reagent Kits

14.8.3.2.2. By Disease

14.8.3.2.3. By End User

14.8.4. U.K. Market Analysis

14.8.4.1. Introduction

14.8.4.2. Market Analysis and Forecast by Market Taxonomy

14.8.4.2.1. By Reagent Kits

14.8.4.2.2. By Disease

14.8.4.2.3. By End User

14.8.5. Spain Market Analysis

14.8.5.1. Introduction

14.8.5.2. Market Analysis and Forecast by Market Taxonomy

14.8.5.2.1. By Reagent Kits

14.8.5.2.2. By Disease

14.8.5.2.3. By End User

14.8.6. BENELUX Market Analysis

14.8.6.1. Introduction

14.8.6.2. Market Analysis and Forecast by Market Taxonomy

14.8.6.2.1. By Reagent Kits

14.8.6.2.2. By Disease

14.8.6.2.3. By End User

14.8.7. Russia Market Analysis

14.8.7.1. Introduction

14.8.7.2. Market Analysis and Forecast by Market Taxonomy

14.8.7.2.1. By Reagent Kits

14.8.7.2.2. By Disease

14.8.7.2.3. By End User

15. East Asia Market Analysis 2014–2022 and Forecast 2023–2033

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014–2022

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

15.3.1. By Country

15.3.1.1. China

15.3.1.2. Japan

15.3.1.3. South Korea

15.3.2. By Reagent Kits

15.3.3. By Disease

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Reagent Kits

15.4.3. By Disease

15.4.4. By End User

15.5. Market Trends

15.6. Key Market Participants - Intensity Mapping

15.7. Drivers and Restraints - Impact Analysis

15.8. Country Level Analysis & Forecast

15.8.1. China Market Analysis

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Reagent Kits

15.8.1.2.2. By Disease

15.8.1.2.3. By End User

15.8.2. Japan Market Analysis

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Reagent Kits

15.8.2.2.2. By Disease

15.8.2.2.3. By End User

15.8.3. South Korea Market Analysis

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. By Reagent Kits

15.8.3.2.2. By Disease

15.8.3.2.3. By End User

16. South Asia Market Analysis 2014–2022 and Forecast 2023–2033

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014–2022

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

16.3.1. By Country

16.3.1.1. India

16.3.1.2. Indonesia

16.3.1.3. Malaysia

16.3.1.4. Thailand

16.3.1.5. Rest of South Asia

16.3.2. By Reagent Kits

16.3.3. By Disease

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Reagent Kits

16.4.2. By Disease

16.4.3. By End User

16.5. Market Trends

16.6. Key Market Participants - Intensity Mapping

16.7. Drivers and Restraints - Impact Analysis

16.8. Country Level Analysis & Forecast

16.8.1. India Market Analysis

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Reagent Kits

16.8.1.2.2. By Disease

16.8.1.2.3. By End User

16.8.2. Indonesia Market Analysis

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Reagent Kits

16.8.2.2.2. By Disease

16.8.2.2.3. By End User

16.8.3. Malaysia Market Analysis

16.8.3.1. Introduction

16.8.3.2. Market Analysis and Forecast by Market Taxonomy

16.8.3.2.1. By Reagent Kits

16.8.3.2.2. By Disease

16.8.3.2.3. By End User

16.8.4. Thailand Market Analysis

16.8.4.1. Introduction

16.8.4.2. Market Analysis and Forecast by Market Taxonomy

16.8.4.2.1. By Reagent Kits

16.8.4.2.2. By Disease

16.8.4.2.3. By End User

17. Oceania Market 2014-2022 and Forecast 2023-2033

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014–2022

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Reagent Kits

17.3.3. By Disease

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Reagent Kits

17.4.2. By Disease

17.4.3. By End User

17.5. Market Trends

17.6. Key Market Participants - Intensity Mapping

17.7. Drivers and Restraints - Impact Analysis

17.8. Country Level Analysis & Forecast

17.8.1. Australia Market Analysis

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Reagent Kits

17.8.1.2.2. By Disease

17.8.1.2.3. By End User

17.8.2. New Zealand Market Analysis

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Reagent Kits

17.8.2.2.2. By Disease

17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2014–2022 and Forecast 2023–2033

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014–2022

18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Türkiye

18.3.1.3. North Africa

18.3.1.4. South Africa

18.3.1.5. Rest of Middle East and Africa

18.3.2. By Reagent Kits

18.3.3. By Disease

18.3.4. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Reagent Kits

18.4.3. By Disease

18.4.4. By End User

18.5. Market Trends

18.6. Key Market Participants - Intensity Mapping

18.7. Drivers and Restraints - Impact Analysis

18.8. Country Level Analysis & Forecast

18.8.1. GCC Countries Market Analysis

18.8.1.1. Introduction

18.8.1.2. Market Analysis and Forecast by Market Taxonomy

18.8.1.2.1. By Reagent Kits

18.8.1.2.2. By Disease

18.8.1.2.3. By End User

18.8.2. Türkiye Market Analysis

18.8.2.1. Introduction

18.8.2.2. Market Analysis and Forecast by Market Taxonomy

18.8.2.2.1. By Reagent Kits

18.8.2.2.2. By Disease

18.8.2.2.3. By End User

18.8.3. South Africa Market Analysis

18.8.3.1. Introduction

18.8.3.2. Market Analysis and Forecast by Market Taxonomy

18.8.3.2.1. By Reagent Kits

18.8.3.2.2. By Disease

18.8.3.2.3. By End User

18.8.4. North Africa Market Analysis

18.8.4.1. Introduction

18.8.4.2. Market Analysis and Forecast by Market Taxonomy

18.8.4.2.1. By Reagent Kits

18.8.4.2.2. By Disease

18.8.4.2.3. By End User

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Share Analysis of Top Players

19.3. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard

20.2. Branding and Promotional Strategies

20.3. Key Development Analysis

20.4. Competition Deep Dive

20.4.1. HiMedia Laboratories

20.4.1.1. Overview

20.4.1.2. Product Portfolio

20.4.1.3. Sales Footprint

20.4.1.4. Key Financials

20.4.1.5. SWOT Analysis

20.4.1.6. Strategy Overview

20.4.1.6.1. Marketing Strategy

20.4.1.6.2. Product Strategy

20.4.1.6.3. Channel Strategy

20.4.2. HiMedia Laboratories

20.4.2.1. Overview

20.4.2.2. Product Portfolio

20.4.2.3. Sales Footprint

20.4.2.4. Key Financials

20.4.2.5. SWOT Analysis

20.4.2.6. Strategy Overview

20.4.2.6.1. Marketing Strategy

20.4.2.6.2. Product Strategy

20.4.2.6.3. Channel Strategy

20.4.3. Speedy Assay Sdn Bhd

20.4.3.1. Overview

20.4.3.2. Product Portfolio

20.4.3.3. Sales Footprint

20.4.3.4. Key Financials

20.4.3.5. SWOT Analysis

20.4.3.6. Strategy Overview

20.4.3.6.1. Marketing Strategy

20.4.3.6.2. Product Strategy

20.4.3.6.3. Channel Strategy

20.4.4. REAGEN LLC

20.4.4.1. Overview

20.4.4.2. Product Portfolio

20.4.4.3. Sales Footprint

20.4.4.4. Key Financials

20.4.4.5. SWOT Analysis

20.4.4.6. Strategy Overview

20.4.4.6.1. Marketing Strategy

20.4.4.6.2. Product Strategy

20.4.4.6.3. Channel Strategy

20.4.5. FUJIKURA KASEI CO., LTD.

20.4.5.1. Overview

20.4.5.2. Product Portfolio

20.4.5.3. Sales Footprint

20.4.5.4. Key Financials

20.4.5.5. SWOT Analysis

20.4.5.6. Strategy Overview

20.4.5.6.1. Marketing Strategy

20.4.5.6.2. Product Strategy

20.4.5.6.3. Channel Strategy

20.4.6. GeneReach Biotechnology Corp.

20.4.6.1. Overview

20.4.6.2. Product Portfolio

20.4.6.3. Sales Footprint

20.4.6.4. Key Financials

20.4.6.5. SWOT Analysis

20.4.6.6. Strategy Overview

20.4.6.6.1. Marketing Strategy

20.4.6.6.2. Product Strategy

20.4.6.6.3. Channel Strategy

20.4.7. Thermo Fisher Scientific

20.4.7.1. Overview

20.4.7.2. Product Portfolio

20.4.7.3. Sales Footprint

20.4.7.4. Key Financials

20.4.7.5. SWOT Analysis

20.4.7.6. Strategy Overview

20.4.7.6.1. Marketing Strategy

20.4.7.6.2. Product Strategy

20.4.7.6.3. Channel Strategy

20.4.8. Lab - Ind Resource Sdn Bhd.

20.4.8.1. Overview

20.4.8.2. Product Portfolio

20.4.8.3. Sales Footprint

20.4.8.4. Key Financials

20.4.8.5. SWOT Analysis

20.4.8.6. Strategy Overview

20.4.8.6.1. Marketing Strategy

20.4.8.6.2. Product Strategy

20.4.8.6.3. Channel Strategy

20.4.9. SUREBIO

20.4.9.1. Overview

20.4.9.2. Product Portfolio

20.4.9.3. Sales Footprint

20.4.9.4. Key Financials

20.4.9.5. SWOT Analysis

20.4.9.6. Strategy Overview

20.4.9.6.1. Marketing Strategy

20.4.9.6.2. Product Strategy

20.4.9.6.3. Channel Strategy

20.4.10. Auro Biotechnologies Pvt. Ltd.

20.4.10.1. Overview

20.4.10.2. Product Portfolio

20.4.10.3. Sales Footprint

20.4.10.4. Key Financials

20.4.10.5. SWOT Analysis

20.4.10.6. Strategy Overview

20.4.10.6.1. Marketing Strategy

20.4.10.6.2. Product Strategy

20.4.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

ページTOPに戻る

図表リスト

Table 1: Global Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 2: Global Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 3: Global Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

Table 4: Global Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Region

Table 5: North America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023–2033, by Country

Table 6: North America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 7: North America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 8: North America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

Table 9: Latin America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023–2033, by Country

Table 10: Latin America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 11: Latin America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 12: Latin America Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

Table 13: Europe Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023–2033, by Country

Table 14: Europe Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 15: Europe Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 16: Europe Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

Table 17: South Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023–2033, by Country

Table 18: South Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 19: South Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 20: South Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

Table 21: East Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023–2033, by Country

Table 22: East Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 23: East Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 24: East Asia Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

Table 25: Oceania Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023–2033, by Country

Table 26: Oceania Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 27: Oceania Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 28: Oceania Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

Table 29: Middle East and Africa Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023–2033, by Country

Table 30: Middle East and Africa Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Reagent Kits

Table 31: Middle East and Africa Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by Disease

Table 32: Middle East and Africa Shrimp Disease Diagnostics Market Value (US$ Mn) Analysis and Forecast 2014–2033, by End User

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Shrimp Disease Diagnostics Market: Scope of the Report

The latest publication by Persistence Market Research on the global shrimp disease diagnostics market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 – 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for shrimp disease diagnostic products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the shrimp disease diagnostics market. Shareholders in the shrimp disease diagnostics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro as well as microeconomic variables affecting the business scenario in the shrimp disease diagnostics market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the shrimp disease diagnostics market offers information divided into four important segments - reagent kits, disease, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Reagent Kits
Rapid Testing Kits
Assay Based Kits
Disease
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
End User
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for shrimp disease diagnostics over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the shrimp disease diagnostics market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the shrimp disease diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the shrimp disease diagnostics market are more accurate and reliable.

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

分子診断ツールの進化とエビ食品産業の成長がエビ病診断薬市場を促進する

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?